Can mucoid Pseudomonas aeruginosa be eradicated in children with cystic fibrosis?
Authors:
- Helen McPhersonHMHelen McPherson
- Mark RosenthalMRMark Rosenthal
- Andrew BushABAndrew Bush
- 6 May 2010
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 45 (6) , 566-568
Abstract
Pseudomonas aeruginosa (PsA) is the most common pathogen to cause chronic lung infection in children with cystic fibrosis (CF), and is associated with an increase in both morbidity and mortality. Whilst the non‐mucoid strain can be eradicated, it is believed that mucoid PsA is difficult, if not impossible, to eradicate. We hypothesized that with modern and aggressive antibiotic regimes, mucoid PsA can be eradicated in children with CF. We investigated this hypothesis through a retrospective review of respiratory tract cultures of children with CF at The Royal Brompton Hospital, London. Children aged under 16 with a confirmed diagnosis of CF and mucoid PsA on respiratory tract culture during a defined 9‐year period were eligible for inclusion. Respiratory tract culture results were followed up for each patient to establish whether children remained infected with mucoid PsA and specifically to identify clearance of infection. Factors which may have been associated with persistence or clearance were also sought. One hundred sixteen children had the minimum dataset, and of these patients 67 (58%) cleared mucoid PsA for more than 1 year. Of the 67 patients who cleared mucoid PsA for more than 1 year, 38 (57%) patients remained clear of mucoid PsA at the last available culture (median 30, range 2–106 clear cultures, and median 55, 12–103 months clear). We conclude that isolation of mucoid PsA does not necessarily equate to lifelong infection. We suggest that trials of eradication of mucoid PsA at first isolation are required. Pediatr Pulmonol. 2010; 45:566–568.Keywords
This publication has 10 references indexed in Scilit:
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus ReportThe Journal of Pediatrics, 2008
- Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditionsJournal of Clinical Investigation, 2006
- Longitudinal Development of Mucoid Pseudomonas aeruginosa Infection and Lung Disease Progression in Children With Cystic FibrosisJAMA, 2005
- Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patientsJournal of Cystic Fibrosis, 2003
- Persistent and aggressive bacteria in the lungs of cystic fibrosis childrenBritish Medical Bulletin, 2002
- Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosisThe Lancet, 2001
- Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosisEuropean Respiratory Journal, 2001
- Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepaciaMicrobiological Reviews, 1996
- Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.Microbiological Reviews, 1996
- Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatmentThe Lancet, 1991